Global Injectable Drug Delivery Formulation Market Insights and Forecast to 2026

Global Injectable Drug Delivery Formulation Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Injectable Drug Delivery Formulation Product Introduction
1.2 Market Segments
1.3 Key Injectable Drug Delivery Formulation Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type
1.4.2 Conventional Drug Delivery Formulations
1.4.3 Novel Drug Delivery Formulations
1.4.4 Long-acting Formulations
1.5 Market by Application
1.5.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application
1.5.2 Autoimmune Diseases
1.5.3 Hormonal Disorders
1.5.4 Oncology
1.5.5 Orphan Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Injectable Drug Delivery Formulation Market Size, Estimates and Forecasts
2.1.1 Global Injectable Drug Delivery Formulation Revenue 2015-2026
2.1.2 Global Injectable Drug Delivery Formulation Sales 2015-2026
2.2 Global Injectable Drug Delivery Formulation, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Injectable Drug Delivery Formulation Competitor Landscape by Players
3.1 Injectable Drug Delivery Formulation Sales by Manufacturers
3.1.1 Injectable Drug Delivery Formulation Sales by Manufacturers (2015-2020)
3.1.2 Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2015-2020)
3.2 Injectable Drug Delivery Formulation Revenue by Manufacturers
3.2.1 Injectable Drug Delivery Formulation Revenue by Manufacturers (2015-2020)
3.2.2 Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Injectable Drug Delivery Formulation Revenue in 2019
3.2.5 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Injectable Drug Delivery Formulation Price by Manufacturers
3.4 Injectable Drug Delivery Formulation Manufacturing Base Distribution, Product Types
3.4.1 Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Drug Delivery Formulation Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Injectable Drug Delivery Formulation Market Size by Type (2015-2020)
4.1.1 Global Injectable Drug Delivery Formulation Sales by Type (2015-2020)
4.1.2 Global Injectable Drug Delivery Formulation Revenue by Type (2015-2020)
4.1.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Injectable Drug Delivery Formulation Market Size Forecast by Type (2021-2026)
4.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2021-2026)
4.2.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Injectable Drug Delivery Formulation Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Injectable Drug Delivery Formulation Market Size by Application (2015-2020)
5.1.1 Global Injectable Drug Delivery Formulation Sales by Application (2015-2020)
5.1.2 Global Injectable Drug Delivery Formulation Revenue by Application (2015-2020)
5.1.3 Injectable Drug Delivery Formulation Price by Application (2015-2020)
5.2 Injectable Drug Delivery Formulation Market Size Forecast by Application (2021-2026)
5.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Drug Delivery Formulation Price Forecast by Application (2021-2026)
6 North America
6.1 North America Injectable Drug Delivery Formulation by Country
6.1.1 North America Injectable Drug Delivery Formulation Sales by Country
6.1.2 North America Injectable Drug Delivery Formulation Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Injectable Drug Delivery Formulation Market Facts & Figures by Type
6.3 North America Injectable Drug Delivery Formulation Market Facts & Figures by Application
7 Europe
7.1 Europe Injectable Drug Delivery Formulation by Country
7.1.1 Europe Injectable Drug Delivery Formulation Sales by Country
7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Type
7.3 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Injectable Drug Delivery Formulation by Region
8.1.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Region
8.1.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Type
8.3 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Application
9 Latin America
9.1 Latin America Injectable Drug Delivery Formulation by Country
9.1.1 Latin America Injectable Drug Delivery Formulation Sales by Country
9.1.2 Latin America Injectable Drug Delivery Formulation Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Injectable Drug Delivery Formulation Market Facts & Figures by Type
9.3 Central & South America Injectable Drug Delivery Formulation Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Injectable Drug Delivery Formulation by Country
10.1.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country
10.1.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Type
10.3 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Application
11 Company Profiles
11.1 Becton, Dickinson and Company (US)
11.1.1 Becton, Dickinson and Company (US) Corporation Information
11.1.2 Becton, Dickinson and Company (US) Description and Business Overview
11.1.3 Becton, Dickinson and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
11.1.5 Becton, Dickinson and Company (US) Related Developments
11.2 Baxter International Inc. (US)
11.2.1 Baxter International Inc. (US) Corporation Information
11.2.2 Baxter International Inc. (US) Description and Business Overview
11.2.3 Baxter International Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
11.2.5 Baxter International Inc. (US) Related Developments
11.3 Gerresheimer AG (Germany)
11.3.1 Gerresheimer AG (Germany) Corporation Information
11.3.2 Gerresheimer AG (Germany) Description and Business Overview
11.3.3 Gerresheimer AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
11.3.5 Gerresheimer AG (Germany) Related Developments
11.4 Pfizer, Inc. (US)
11.4.1 Pfizer, Inc. (US) Corporation Information
11.4.2 Pfizer, Inc. (US) Description and Business Overview
11.4.3 Pfizer, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
11.4.5 Pfizer, Inc. (US) Related Developments
11.5 Schott AG (Germany)
11.5.1 Schott AG (Germany) Corporation Information
11.5.2 Schott AG (Germany) Description and Business Overview
11.5.3 Schott AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
11.5.5 Schott AG (Germany) Related Developments
11.6 Sandoz (Germany)
11.6.1 Sandoz (Germany) Corporation Information
11.6.2 Sandoz (Germany) Description and Business Overview
11.6.3 Sandoz (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
11.6.5 Sandoz (Germany) Related Developments
11.7 Teva Pharmaceutical Industries Ltd. (Israel)
11.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
11.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Related Developments
11.8 Eli Lilly and Company (US)
11.8.1 Eli Lilly and Company (US) Corporation Information
11.8.2 Eli Lilly and Company (US) Description and Business Overview
11.8.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
11.8.5 Eli Lilly and Company (US) Related Developments
11.1 Becton, Dickinson and Company (US)
11.1.1 Becton, Dickinson and Company (US) Corporation Information
11.1.2 Becton, Dickinson and Company (US) Description and Business Overview
11.1.3 Becton, Dickinson and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
11.1.5 Becton, Dickinson and Company (US) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Injectable Drug Delivery Formulation Market Estimates and Projections by Region
12.1.1 Global Injectable Drug Delivery Formulation Sales Forecast by Regions 2021-2026
12.1.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Regions 2021-2026
12.2 North America Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.2.1 North America: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.2.2 North America: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.2.3 North America: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.3 Europe Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.3.1 Europe: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.3.2 Europe: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.3.3 Europe: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Injectable Drug Delivery Formulation Market Size Forecast by Region (2021-2026)
12.5 Latin America Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.5.1 Latin America: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.5.2 Latin America: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.5.3 Latin America: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Injectable Drug Delivery Formulation Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Injectable Drug Delivery Formulation Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Injectable Drug Delivery Formulation Market Segments
Table 2. Ranking of Global Top Injectable Drug Delivery Formulation Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Conventional Drug Delivery Formulations
Table 5. Major Manufacturers of Novel Drug Delivery Formulations
Table 6. Major Manufacturers of Long-acting Formulations
Table 7. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Injectable Drug Delivery Formulation Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Injectable Drug Delivery Formulation Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Injectable Drug Delivery Formulation Sales Market Share by Regions (2015-2020)
Table 11. Global Injectable Drug Delivery Formulation Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Injectable Drug Delivery Formulation Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Injectable Drug Delivery Formulation Sales Share by Manufacturers (2015-2020)
Table 14. Global Injectable Drug Delivery Formulation Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drug Delivery Formulation as of 2019)
Table 16. Injectable Drug Delivery Formulation Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Injectable Drug Delivery Formulation Price (2015-2020) (USD/Pcs)
Table 19. Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Injectable Drug Delivery Formulation Product Type
Table 21. Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 24. Global Injectable Drug Delivery Formulation Sales Share by Type (2015-2020)
Table 25. Global Injectable Drug Delivery Formulation Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Injectable Drug Delivery Formulation Revenue Share by Type (2015-2020)
Table 27. Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 29. Global Injectable Drug Delivery Formulation Sales Share by Application (2015-2020)
Table 30. North America Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 31. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 32. North America Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 34. North America Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 35. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 36. North America Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 37. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 38. Europe Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 40. Europe Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 42. Europe Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 44. Europe Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 54. Latin America Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 58. Latin America Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 60. Latin America Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 70. Becton, Dickinson and Company (US) Corporation Information
Table 71. Becton, Dickinson and Company (US) Description and Major Businesses
Table 72. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Becton, Dickinson and Company (US) Product
Table 74. Becton, Dickinson and Company (US) Recent Development
Table 75. Baxter International Inc. (US) Corporation Information
Table 76. Baxter International Inc. (US) Description and Major Businesses
Table 77. Baxter International Inc. (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Baxter International Inc. (US) Product
Table 79. Baxter International Inc. (US) Recent Development
Table 80. Gerresheimer AG (Germany) Corporation Information
Table 81. Gerresheimer AG (Germany) Description and Major Businesses
Table 82. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Gerresheimer AG (Germany) Product
Table 84. Gerresheimer AG (Germany) Recent Development
Table 85. Pfizer, Inc. (US) Corporation Information
Table 86. Pfizer, Inc. (US) Description and Major Businesses
Table 87. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Pfizer, Inc. (US) Product
Table 89. Pfizer, Inc. (US) Recent Development
Table 90. Schott AG (Germany) Corporation Information
Table 91. Schott AG (Germany) Description and Major Businesses
Table 92. Schott AG (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Schott AG (Germany) Product
Table 94. Schott AG (Germany) Recent Development
Table 95. Sandoz (Germany) Corporation Information
Table 96. Sandoz (Germany) Description and Major Businesses
Table 97. Sandoz (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Sandoz (Germany) Product
Table 99. Sandoz (Germany) Recent Development
Table 100. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 101. Teva Pharmaceutical Industries Ltd. (Israel) Description and Major Businesses
Table 102. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceutical Industries Ltd. (Israel) Product
Table 104. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 105. Eli Lilly and Company (US) Corporation Information
Table 106. Eli Lilly and Company (US) Description and Major Businesses
Table 107. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Eli Lilly and Company (US) Product
Table 109. Eli Lilly and Company (US) Recent Development
Table 110. Global Injectable Drug Delivery Formulation Sales Forecast by Regions (2021-2026) (K Pcs)
Table 111. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Injectable Drug Delivery Formulation Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. North America: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Europe: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Injectable Drug Delivery Formulation Sales Forecast by Region (2021-2026) (K Pcs)
Table 119. Asia Pacific: Injectable Drug Delivery Formulation Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. Latin America: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Middle East and Africa: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Injectable Drug Delivery Formulation Players
Table 128. Injectable Drug Delivery Formulation Customers List
Table 129. Injectable Drug Delivery Formulation Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Drug Delivery Formulation Product Picture
Figure 2. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2020 & 2026
Figure 3. Conventional Drug Delivery Formulations Product Picture
Figure 4. Novel Drug Delivery Formulations Product Picture
Figure 5. Long-acting Formulations Product Picture
Figure 6. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2020 & 2026
Figure 7. Autoimmune Diseases
Figure 8. Hormonal Disorders
Figure 9. Oncology
Figure 10. Orphan Diseases
Figure 11. Others
Figure 12. Injectable Drug Delivery Formulation Report Years Considered
Figure 13. Global Injectable Drug Delivery Formulation Market Size 2015-2026 (US$ Million)
Figure 14. Global Injectable Drug Delivery Formulation Sales 2015-2026 (K Pcs)
Figure 15. Global Injectable Drug Delivery Formulation Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2015-2020)
Figure 17. Global Injectable Drug Delivery Formulation Sales Market Share by Region in 2019
Figure 18. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2015-2020)
Figure 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Region in 2019
Figure 20. Global Injectable Drug Delivery Formulation Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Injectable Drug Delivery Formulation Revenue in 2019
Figure 22. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2019
Figure 25. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2015-2020)
Figure 26. Global Injectable Drug Delivery Formulation Revenue Market Share by Type in 2019
Figure 27. Global Injectable Drug Delivery Formulation Market Share by Price Range (2015-2020)
Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Figure 29. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2019
Figure 30. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2015-2020)
Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2019
Figure 32. North America Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 35. North America Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 36. U.S. Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 41. North America Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 42. Europe Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 45. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 46. Germany Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 57. Europe Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 58. Asia Pacific Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region in 2019
Figure 61. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region in 2019
Figure 62. China Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs